Concordia Healthcare (NASDAQ: CXRX) recently received a number of ratings updates from brokerages and research firms: 9/14/2015 – Concordia Healthcare was downgraded by analysts at Zacks from a “strong-buy” rating to a “hold” rating. According to Zacks, “Concordia Healthcare Corp. operates as a healthcare business which includes the management and acquisition of legacy pharmaceutical products […]
